Get the Stockscreener App
72.25
2.08%
-1.4849
Henry Schein Inc stock is traded at $72.25, with a volume of 459.74K.
It is down -2.08% in the last 24 hours and up +0.85% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
See More
Previous Close:
$73.73
Open:
$73.6
24h Volume:
459.74K
Relative Volume:
0.29
Market Cap:
$9.34B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
21.12
EPS:
3.42
Net Cash Flow:
$421.00M
1W Performance:
+8.51%
1M Performance:
+0.85%
6M Performance:
-1.43%
1Y Performance:
+4.76%
1-Day Range:
$71.98
$73.60
1-Week Range:
$66.17
$76.84
52-Week Range:
$63.67
$82.63
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| HSIC | 72.45 | 9.34B | 12.50B | 314.00M | 421.00M | 3.42 |
| MCK | 626.41 | 80.02B | 330.19B | 2.54B | 4.31B | 25.31 |
| COR | 243.62 | 47.55B | 293.96B | 1.51B | 3.00B | 8.53 |
| CAH | 122.08 | 29.03B | 224.34B | 1.26B | 1.08B | 0.61 |
| PDCO | 20.09 | 1.76B | 6.57B | 185.93M | -857.00M | 2.19 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein to acquire medical supplier Acentus - MedTech Dive
Henry Schein to Participate in Investor Conferences in December - Business Wire
Henry Schein shake-up sought by investment fund that calls for cost cuts, higher profits, new board - Newsday
Henry Schein: Another Day, Another Purchase (NASDAQ:HSIC) - Seeking Alpha
Henry Schein's COO Michael Ettinger sells $918,000 in stock - Investing.com
$35 million Tampa medical supply company acquired - Business Observer
Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products - BioSpace
Henry Schein to Buy Homecare Medical Product Supplier Acentus - MPO-mag
Nuance Investments LLC Has $166.07 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Peering Into Henry Schein's Recent Short Interest - Benzinga
Henry Schein to acquire Acentus, terms not disclosed - TipRanks
Henry Schein Expands Medical Supply Empire with $35M Acentus Acquisition | HSIC Stock News - StockTitan
Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say - MSN
Henry Schein extends gain on report of activist stake, push for board changes - MSN
Henry Schein shares retain Overweight rating as Piper Sandler comments on Ananym Capital proposals - Investing.com
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Ananym Capital Management Pushes for Changes at Henry Schein - Marketscreener.com
Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say By Reuters - Investing.com
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say - Reuters
Dental company stocks jump amid RFK Jr.'s health claims about fluoride - CBS News
A dental stock rises as RFK Jr. threatens to remove fluoride from America's water - Quartz
U.S. STOCKS Henry Schein Inc, Palantir Technologies, Uber Technologies - XM
Ananym urges Henry Schein to cut spending, sell unit, Reuters reports - TipRanks
Exclusive-Activist Investor Ananym Capital Pushes for Changes at Henry Schein, Sources Say - U.S News & World Report Money
Henry Schein gains amid activist speculation after 13F filing, conference appearance - Seeking Alpha
Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits - MSN
Dental supply stock surges on RFK's anti-fluoride stance, activist involvement - CNBC
Clarkston Capital Partners LLC Purchases 71,560 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 33,053 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Curi RMB Capital LLC Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
UBS: Henry Schein, Inc. (NASDAQ:HSIC) Is A Bottom-Ranked Quant Stock - Insider Monkey
Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by KBC Group NV - MarketBeat
First Week of July 2025 Options Trading For Henry Schein (HSIC) - Nasdaq
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
ING Groep NV Takes $63.23 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Al Gore's Firm Reduces Stake in Henry Schein Inc - GuruFocus.com
Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Speece Thorson Capital Group Inc. - MarketBeat
Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings - Simply Wall St
Some Investors May Be Willing To Look Past Henry Schein's (NASDAQ:HSIC) Soft Earnings - Yahoo Finance
Amalgamated Bank Has $1.82 Million Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors - Insider Monkey
Artisan Partners Limited Partnership Bolsters Stake in Henry Sch - GuruFocus.com
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
River Global Investors LLP Raises Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Inc. stock underperforms Friday when compared to competitors - MarketWatch
Tandem Investment Advisors Inc. Sells 27,748 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
FY2025 EPS Estimates for Henry Schein Decreased by Analyst - MarketBeat
William Blair Predicts Increased Earnings for Henry Schein - MarketBeat
Brokers Set Expectations for Henry Schein FY2024 Earnings - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Q3 2024 Earnings Call Transcript - Insider Monkey
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):